Peptide supplier for telehealth companies and programs
Short answerA telehealth company can apply to International Wholesale Peptides today. It can buy cosmetic and other non-medicine goods direct under its brand, have its partner pharmacy hold the account for bulk API with the program named on the order, and get the route in writing for its operations and legal teams.

- Buy direct today
- Cosmetic and other non-medicine goods, on a trade label or your brand
- Product for patients
- Your partner pharmacy holds the account, with the program named on the order
- Route
- Confirmed in writing
- May a telehealth company apply
- Yes
- Per-order dispatch
- By agreement, for finished non-prescription goods only
- What the pharmacy buys
- Bulk API with a certificate of analysis per lot
A peptide supplier for telehealth companies should start with what the company can do today. A telehealth brand can buy cosmetic and other non-medicine goods direct from International Wholesale Peptides (IWP). Its partner pharmacy can hold the account for bulk API, with the program named on the order. We set out the route in writing for operations and legal teams. Telehealth companies may apply.
What a telehealth company can do today
A telehealth company or program may apply for a trade account. Three things are open now, in this order.
- Buy non-medicine goods direct. Finished cosmetic skincare, hair and scalp care and other goods that are lawfully classified as non-medicines in the market of sale, on our trade label or your own brand. See the private label page. They ship to the registered business address with a certificate of analysis for the active and an origin statement per lot.
- Have your partner pharmacy hold the account, with the program named on the order. The licensed party buys, receives the goods and keeps the lot documents for anything that is a medicine in your market. The order names the program it is for, so both sides work from the same lot number, certificate and origin statement.
- Get the route in writing. Send your state or country and the product class. We reply in writing with the licensed party the route requires and the documents that travel with each lot.
Start on the application page and say which of the three you need. The page on how a trade account works shows what an approved account receives.

Who this page is for
This page is for founders, operations and supply leads, and general counsel at telehealth companies and at brands adding a telehealth program. It is also for the pharmacy partnerships manager who has been asked to "bring supply in-house" and needs to know which parts of that are possible.
What a telehealth company can buy
| Product class | Typical pack | Documents | Route |
|---|---|---|---|
| Bulk peptide API powder | Sealed containers | Certificate of analysis, origin statement, lot file naming synthesis and fill-and-finish sites where applicable | Sold to the partner pharmacy, which holds the account with the program named on the order |
| Patient-use compounded product | Dispensed and shipped by the pharmacy | Pharmacy labels and records | From the pharmacy on prescription. The pharmacy holds the account with us |
| Private-label cosmetic goods | Jars and bottles under the brand's label | Certificate of analysis for the active, ingredient list, origin statement | Direct to the brand entity; typically from 250 units |
| Other finished non-drug formats | By quote | Lot documents and ingredient list | Direct, only where lawfully classified as a cosmetic or supplement in the market of sale |
The product class, not the buyer's wish, decides the route.
The lawful route for a telehealth program
This summary is as of November 2026 and is not legal advice. Telehealth law changes often, and counsel should confirm each point.
Three entities, three roles. Many US states restrict who may own a medical practice. A common structure has a management company that owns the brand and the software, a physician-owned medical group that employs the prescribers, and one or more independent pharmacies. The prescriber decides. The pharmacy dispenses. The platform markets and coordinates. Product for patients moves only between the pharmacy and the patient.
The pharmacy needs a license for every state it ships into. Most states require a nonresident pharmacy license or registration. A national program therefore depends on its pharmacy network's license footprint, not on its supplier.
Patient-specific prescriptions. A 503A pharmacy compounds for an identified patient on a valid prescription. Whether a given peptide may be compounded is unsettled for several substances, and the pharmacy must confirm the position. The 503A and 503B peptide sourcing guide explains the framework, and the clinics page sets out the general route for any practice.
Outside the United States. Patient-use product goes through a licensed importer or licensed pharmacy in the destination country. Some countries restrict remote prescribing or supply by mail. We confirm the route in writing before taking an order. We supply worldwide wherever a lawful route exists for the product and the buyer. Every country is assessed on request, and where a market restricts a product class the route is assessed case by case and confirmed in writing.
How telehealth companies buy supply
Telehealth supply decisions are made by a small group, and the supplier conversation usually happens at one remove.
| Decision | Who signs off | What they ask |
|---|---|---|
| Which products the program offers | Clinical lead of the medical group | What the pharmacy can lawfully compound, by state |
| Which pharmacies join the network | Pharmacy partnerships and legal | Licenses by state, capacity, turnaround, testing, integration |
| Which API supplier the pharmacy uses | The pharmacist in charge. The platform may ask but cannot direct | Manufacturer, certificates, endotoxin results, origin, continuity |
| Marketing claims | Legal and compliance | What can be said about a compounded product and its source |
| Own-brand consumer goods | Brand or commerce lead | Artwork process, minimums, lead time |
A platform can ask its pharmacies to consider a supplier. It cannot buy the API itself and hand it to the pharmacy without becoming part of the drug supply chain, with the licensing that implies. The clean arrangement is for each pharmacy to apply as a compounding pharmacy and qualify us under its own procedures.
What scale changes
Telehealth volume is steady and forecastable, which changes what the pharmacy needs from an API supplier.
- Lot continuity. A pharmacy filling the same prescription for many patients wants one qualified lot drawn down over months. Reserved lots are part of a supply program, open to accounts ordering in the top band of US$30,000 and over.
- Forward schedule. A forward supply schedule lets the pharmacy plan compounding runs around known receipts.
- Two-pharmacy redundancy. Telehealth companies often split volume across two pharmacies. Each holds its own account and its own lot files.
- Document flow. Compliance teams ask the pharmacy for the lot file at audit. Each certificate of analysis names the testing laboratory, and lot numbers can be checked on the lot lookup.
Limits that apply
Prescription product reaches a patient only from the dispensing pharmacy. Per-order dispatch from a fulfilment partner covers finished non-prescription goods only, and nothing is sent to individuals on our account. Wording about a compounded product is the pharmacy's and the prescriber's to approve. A program's advertising is its own responsibility, and source statements must match the lot file exactly. Origin is stated per lot.

Own-brand goods for telehealth brands
Many telehealth brands sell consumer products beside their clinical services. Cosmetic skincare under the brand's label is a direct purchase, typically from 250 units, and a first order takes 4 to 6 weeks from approved artwork. Stock can ship in bulk to the brand's registered site or, by agreement, per order under the brand's label. The private label page explains label options and who is responsible for what. The brand entity is the party that places the product on the market and carries its claims and filings.
What we need at application
| Item | Why we ask |
|---|---|
| Legal names of the management company and the medical group, with states of operation | To understand the structure and who we may deal with |
| Name, license number and states of license for each partner pharmacy | To direct API supply to the licensed party |
| Named compliance contact | To have one person for regulatory questions |
| Product classes of interest, separated into clinical and consumer | To state the route for each class |
| For consumer goods: brand name, trademark status and countries of sale | To plan artwork and confirm the route in writing |
| Confirmation that no product will be requested for shipment to individuals | To keep the account within trade-only supply |
Pharmacies and brand entities apply through the application page. All buyer types are on the buyers hub.
Research-grade product
Research-grade product is supplied to verified research institutions; see the page for research institutions.
Frequently asked questions
Can a telehealth company buy from IWP?
A telehealth company may apply. It buys cosmetic and other non-medicine goods direct under its own brand. For product that is a medicine, its partner pharmacy holds the account in the pharmacy's own name, with the program named on the order, compounds on prescription and ships to the patient. We set out this route in writing.
Can IWP ship directly to our patients?
A patient receives prescription product only from the licensed pharmacy that fills the prescription, and that pharmacy must hold the license each destination state requires. For finished non-prescription goods under the brand's label, per-order dispatch from a fulfilment partner is available by agreement. Nothing is sent to individuals on our account.
Can vials carry our telehealth brand?
The label on a dispensed prescription is the pharmacy's, and its content is set by pharmacy law. Some pharmacies add program branding to outer packaging under their own procedures. Private label from us is for trade products and cosmetic goods, and we do not apply a telehealth brand to any other product class.
Which entity should apply: the platform, the medical group or the pharmacy?
The pharmacy, for API. In a typical structure a management company runs the platform, a physician-owned medical group employs the prescribers, and an independent pharmacy dispenses. Only the pharmacy can buy API. The management company can apply separately for cosmetic or other lawfully classified non-drug goods.
Can a telehealth company outside the United States use IWP?
Through a licensed importer or licensed pharmacy in the destination country, where a lawful route exists for the product. Rules on remote prescribing and on supply by mail differ by country. We confirm the route in writing before taking an order, and we do not serve some countries.
What do partner pharmacies ask IWP for?
The manufacturer and site for each API, the certificate of analysis naming the testing laboratory, endotoxin results where relevant, the origin statement, and continuity of supply. Pharmacies serving telehealth volume usually ask about reserved lots and a forward supply schedule, which are part of a supply program for accounts in the top price band.


